Rocket Lab (RKLB) shares closed at $73.92 on October 2 after surging nearly 5% on a record 20-mission Electron launch contract with Synspective, which pushed the company’s backlog above 100 missions and locked in multi-year revenue visibility through 2031. Citi’s initiation of coverage with a Buy rating and $105 price target added fresh institutional momentum, while ARK Invest accumulated additional shares. These developments reinforced trader focus on Electron demand and the still-pending Neutron debut, even as Q3 2026 earnings (due November 9) and any final 2026 launch cadence remain key near-term variables. The stock trades well below its $151 52-week high amid elevated volatility typical of growth aerospace names.